Viewing Study NCT03183661


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2026-04-11 @ 11:14 PM
Study NCT ID: NCT03183661
Status: RECRUITING
Last Update Posted: 2023-08-25
First Post: 2017-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial
Sponsor: Anterogen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module